New vitamin B12 therapy shows promise against deadly brain cancer
Researchers have developed a modified vitamin B12 compound, nitrosylcobalamin, that can cross the blood-brain barrier to target glioblastoma tumors. Early studies in animal models show promise for this treatment as a potential therapy for aggressive brain cancer.
Why it matters
Glioblastoma is a highly lethal and treatment-resistant cancer; finding ways to bypass the blood-brain barrier is a critical breakthrough in oncology.
A newly published study in Oncoscience explores a potential new approach to treating glioblastoma, an aggressive form of brain cancer that remains extremely difficult to treat. The paper is titled "Selective blood-brain barrier penetration and tumor targeting of nitrosylcobalamin in glioblastoma: Pharmacokinetics, tissue distribution, and synergistic activity with trail and temozolomide."
The report is a straightforward summary of scientific research findings.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in